Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS
{{output}}
INTRODUCTION: Despite expanding use of plasma biomarkers for Alzheimer's disease (AD), minimal examination has been undertaken in early-onset AD (EOAD). Prior analyses assessed criterion and convergent validity of common plasma biomarkers in a well-characteri... ...
